カテゴリー： LP Information, 世界, 医療/バイオ

世界の抗生物質API市場予測 2021年-2026年

【英語タイトル】Global Antibiotic API Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9413）・商品コード：LPI21MY9413
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：180
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「抗生物質APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他など、用途別には、経口薬、注射薬などにセグメント区分してまとめました。抗生物質APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・抗生物質APIの世界市場概要（サマリー）
・抗生物質APIの企業別販売量・売上
・抗生物質APIの企業別市場シェア
・抗生物質APIの世界市場規模 2016年-2021年：種類別（ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他）
・抗生物質APIの世界市場規模 2016年-2021年：用途別（経口薬、注射薬）
・抗生物質APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・抗生物質APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・抗生物質APIのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗生物質APIの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗生物質API市場の成長要因・課題・動向
・抗生物質APIの世界市場予測 2021年-2026年
・抗生物質APIの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・抗生物質APIのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・抗生物質APIのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・抗生物質APIの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・抗生物質APIの世界市場予測：種類別（ペニシリン、セファロスポリン、アミノグリコシド、テトラサイクリン、キノロン、マクロライド、リンコマイシン、その他）
・抗生物質APIの世界市場予測：用途別（経口薬、注射薬）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Antibiotic API will have significant change from previous year. By the most conservative estimates of global Antibiotic API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5885.2 million in 2019. Over the next five years the Antibiotic API market will register a -0.9% CAGR in terms of revenue, the global market size will reach US$ 5675.6 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Penicillins
Cephalosporins
Aminoglycosides
Tetracyclines
Quinolones
Macrolides
Lincomycins
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oral Medicine
Injection Medicine

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
UNITED LABORATORIES
North China Pharmaceutical
RUIYING PIONEER PHARMACEUTICAL
Centrient Pharmaceuticals
Aurobindo Pharma
Shyndec Pharmaceutical
Nectar Lifesciences
Harbin Pharmaceutical Group
ACS Dobfar
Novartis
CSPC
QILU ANTIBIOTICS PHARMACEUTICAL
REYOUNG
Orchid Pharma
FUAN PHARMACEUTICAL
Dongying Pharmaceutical
FUKANG PHARMACEUTICAL
Medya Pharmaceutical
LUKANG PHARMACEUTICAL
Dawnrays Pharmaceutical
SALUBRIS
KELUN
HUAFANG PHARMACEUTICAL

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibiotic API Consumption 2016-2026
2.1.2 Antibiotic API Consumption CAGR by Region
2.2 Antibiotic API Segment by Type
2.2.1 Penicillins
2.2.2 Cephalosporins
2.2.3 Aminoglycosides
2.2.4 Tetracyclines
2.2.5 Quinolones
2.2.6 Macrolides
2.2.7 Lincomycins
2.2.8 Others
2.3 Antibiotic API Sales by Type
2.3.1 Global Antibiotic API Sales Market Share by Type (2016-2021)
2.3.2 Global Antibiotic API Revenue and Market Share by Type (2016-2021)
2.3.3 Global Antibiotic API Sale Price by Type (2016-2021)
2.4 Antibiotic API Segment by Application
2.4.1 Oral Medicine
2.4.2 Injection Medicine
2.5 Antibiotic API Sales by Application
2.5.1 Global Antibiotic API Sale Market Share by Application (2016-2021)
2.5.2 Global Antibiotic API Revenue and Market Share by Application (2016-2021)
2.5.3 Global Antibiotic API Sale Price by Application (2016-2021)

3 Global Antibiotic API by Company
3.1 Global Antibiotic API Sales Market Share by Company
3.1.1 Global Antibiotic API Sales by Company (2019-2021)
3.1.2 Global Antibiotic API Sales Market Share by Company (2019-2021)
3.2 Global Antibiotic API Revenue Market Share by Company
3.2.1 Global Antibiotic API Revenue by Company (2019-2021)
3.2.2 Global Antibiotic API Revenue Market Share by Company (2019-2021)
3.3 Global Antibiotic API Sale Price by Company
3.4 Global Manufacturers Antibiotic API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibiotic API Product Location Distribution
3.4.2 Players Antibiotic API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antibiotic API by Region
4.1 Global Antibiotic API by Region
4.1.1 Global Antibiotic API Sales by Region
4.1.2 Global Antibiotic API Revenue by Region
4.2 Americas Antibiotic API Sales Growth
4.3 APAC Antibiotic API Sales Growth
4.4 Europe Antibiotic API Sales Growth
4.5 Middle East & Africa Antibiotic API Sales Growth

5 Americas
5.1 Americas Antibiotic API Sales by Country
5.1.1 Americas Antibiotic API Sales by Country (2016-2021)
5.1.2 Americas Antibiotic API Revenue by Country (2016-2021)
5.2 Americas Antibiotic API Sales by Type
5.3 Americas Antibiotic API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Antibiotic API Sales by Region
6.1.1 APAC Antibiotic API Sales by Region (2016-2021)
6.1.2 APAC Antibiotic API Revenue by Region (2016-2021)
6.2 APAC Antibiotic API Sales by Type
6.3 APAC Antibiotic API Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Antibiotic API by Country
7.1.1 Europe Antibiotic API Sales by Country (2016-2021)
7.1.2 Europe Antibiotic API Revenue by Country (2016-2021)
7.2 Europe Antibiotic API Sales by Type
7.3 Europe Antibiotic API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Antibiotic API by Country
8.1.1 Middle East & Africa Antibiotic API Sales by Country (2016-2021)
8.1.2 Middle East & Africa Antibiotic API Revenue by Country (2016-2021)
8.2 Middle East & Africa Antibiotic API Sales by Type
8.3 Middle East & Africa Antibiotic API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antibiotic API Distributors
10.3 Antibiotic API Customer

11 Global Antibiotic API Market Forecast
11.1 Global Antibiotic API Forecast by Region
11.1.1 Global Antibiotic API Forecast by Regions (2021-2026)
11.2.2 Global Antibiotic API Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Antibiotic API Forecast by Type
11.7 Global Antibiotic API Forecast by Application

12 Key Players Analysis
12.1 UNITED LABORATORIES
12.1.1 UNITED LABORATORIES UNITED LABORATORIES Company Information
12.1.2 UNITED LABORATORIES Antibiotic API Product Offered
12.1.3 UNITED LABORATORIES Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 UNITED LABORATORIES Main Business Overview
12.1.5 UNITED LABORATORIES Latest Developments
12.2 North China Pharmaceutical
12.2.1 North China Pharmaceutical Company Information
12.2.2 North China Pharmaceutical Antibiotic API Product Offered
12.2.3 North China Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 North China Pharmaceutical Main Business Overview
12.2.5 North China Pharmaceutical Latest Developments
12.3 RUIYING PIONEER PHARMACEUTICAL
12.3.1 RUIYING PIONEER PHARMACEUTICAL Company Information
12.3.2 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Offered
12.3.3 RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 RUIYING PIONEER PHARMACEUTICAL Main Business Overview
12.3.5 RUIYING PIONEER PHARMACEUTICAL Latest Developments
12.4 Centrient Pharmaceuticals
12.4.1 Centrient Pharmaceuticals Company Information
12.4.2 Centrient Pharmaceuticals Antibiotic API Product Offered
12.4.3 Centrient Pharmaceuticals Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Centrient Pharmaceuticals Main Business Overview
12.4.5 Centrient Pharmaceuticals Latest Developments
12.5 Aurobindo Pharma
12.5.1 Aurobindo Pharma Company Information
12.5.2 Aurobindo Pharma Antibiotic API Product Offered
12.5.3 Aurobindo Pharma Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Aurobindo Pharma Main Business Overview
12.5.5 Aurobindo Pharma Latest Developments
12.6 Shyndec Pharmaceutical
12.6.1 Shyndec Pharmaceutical Company Information
12.6.2 Shyndec Pharmaceutical Antibiotic API Product Offered
12.6.3 Shyndec Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Shyndec Pharmaceutical Main Business Overview
12.6.5 Shyndec Pharmaceutical Latest Developments
12.7 Nectar Lifesciences
12.7.1 Nectar Lifesciences Company Information
12.7.2 Nectar Lifesciences Antibiotic API Product Offered
12.7.3 Nectar Lifesciences Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Nectar Lifesciences Main Business Overview
12.7.5 Nectar Lifesciences Latest Developments
12.8 Harbin Pharmaceutical Group
12.8.1 Harbin Pharmaceutical Group Company Information
12.8.2 Harbin Pharmaceutical Group Antibiotic API Product Offered
12.8.3 Harbin Pharmaceutical Group Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Harbin Pharmaceutical Group Main Business Overview
12.8.5 Harbin Pharmaceutical Group Latest Developments
12.9 ACS Dobfar
12.9.1 ACS Dobfar Company Information
12.9.2 ACS Dobfar Antibiotic API Product Offered
12.9.3 ACS Dobfar Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 ACS Dobfar Main Business Overview
12.9.5 ACS Dobfar Latest Developments
12.10 Novartis
12.10.1 Novartis Company Information
12.10.2 Novartis Antibiotic API Product Offered
12.10.3 Novartis Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis Main Business Overview
12.10.5 Novartis Latest Developments
12.11 CSPC
12.11.1 CSPC Company Information
12.11.2 CSPC Antibiotic API Product Offered
12.11.3 CSPC Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 CSPC Main Business Overview
12.11.5 CSPC Latest Developments
12.12 QILU ANTIBIOTICS PHARMACEUTICAL
12.12.1 QILU ANTIBIOTICS PHARMACEUTICAL Company Information
12.12.2 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Offered
12.12.3 QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 QILU ANTIBIOTICS PHARMACEUTICAL Main Business Overview
12.12.5 QILU ANTIBIOTICS PHARMACEUTICAL Latest Developments
12.13 REYOUNG
12.13.1 REYOUNG Company Information
12.13.2 REYOUNG Antibiotic API Product Offered
12.13.3 REYOUNG Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 REYOUNG Main Business Overview
12.13.5 REYOUNG Latest Developments
12.14 Orchid Pharma
12.14.1 Orchid Pharma Company Information
12.14.2 Orchid Pharma Antibiotic API Product Offered
12.14.3 Orchid Pharma Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Orchid Pharma Main Business Overview
12.14.5 Orchid Pharma Latest Developments
12.15 FUAN PHARMACEUTICAL
12.15.1 FUAN PHARMACEUTICAL Company Information
12.15.2 FUAN PHARMACEUTICAL Antibiotic API Product Offered
12.15.3 FUAN PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 FUAN PHARMACEUTICAL Main Business Overview
12.15.5 FUAN PHARMACEUTICAL Latest Developments
12.16 Dongying Pharmaceutical
12.16.1 Dongying Pharmaceutical Company Information
12.16.2 Dongying Pharmaceutical Antibiotic API Product Offered
12.16.3 Dongying Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Dongying Pharmaceutical Main Business Overview
12.16.5 Dongying Pharmaceutical Latest Developments
12.17 FUKANG PHARMACEUTICAL
12.17.1 FUKANG PHARMACEUTICAL Company Information
12.17.2 FUKANG PHARMACEUTICAL Antibiotic API Product Offered
12.17.3 FUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 FUKANG PHARMACEUTICAL Main Business Overview
12.17.5 FUKANG PHARMACEUTICAL Latest Developments
12.18 Medya Pharmaceutical
12.18.1 Medya Pharmaceutical Company Information
12.18.2 Medya Pharmaceutical Antibiotic API Product Offered
12.18.3 Medya Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Medya Pharmaceutical Main Business Overview
12.18.5 Medya Pharmaceutical Latest Developments
12.19 LUKANG PHARMACEUTICAL
12.19.1 LUKANG PHARMACEUTICAL Company Information
12.19.2 LUKANG PHARMACEUTICAL Antibiotic API Product Offered
12.19.3 LUKANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 LUKANG PHARMACEUTICAL Main Business Overview
12.19.5 LUKANG PHARMACEUTICAL Latest Developments
12.20 Dawnrays Pharmaceutical
12.20.1 Dawnrays Pharmaceutical Company Information
12.20.2 Dawnrays Pharmaceutical Antibiotic API Product Offered
12.20.3 Dawnrays Pharmaceutical Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.20.4 Dawnrays Pharmaceutical Main Business Overview
12.20.5 Dawnrays Pharmaceutical Latest Developments
12.21 SALUBRIS
12.21.1 SALUBRIS Company Information
12.21.2 SALUBRIS Antibiotic API Product Offered
12.21.3 SALUBRIS Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.21.4 SALUBRIS Main Business Overview
12.21.5 SALUBRIS Latest Developments
12.22 KELUN
12.22.1 KELUN Company Information
12.22.2 KELUN Antibiotic API Product Offered
12.22.3 KELUN Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.22.4 KELUN Main Business Overview
12.22.5 KELUN Latest Developments
12.23 HUAFANG PHARMACEUTICAL
12.23.1 HUAFANG PHARMACEUTICAL Company Information
12.23.2 HUAFANG PHARMACEUTICAL Antibiotic API Product Offered
12.23.3 HUAFANG PHARMACEUTICAL Antibiotic API Sales, Revenue, Price and Gross Margin (2019-2021)
12.23.4 HUAFANG PHARMACEUTICAL Main Business Overview
12.23.5 HUAFANG PHARMACEUTICAL Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Antibiotic API Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Penicillins
Table 3. Major Players of Cephalosporins
Table 4. Major Players of Aminoglycosides
Table 5. Major Players of Tetracyclines
Table 6. Major Players of Quinolones
Table 7. Major Players of Macrolides
Table 8. Major Players of Lincomycins
Table 9. Major Players of Others
Table 10. Global Antibiotic API Sales by Type (2016-2021) & (Tons)
Table 11. Global Antibiotic API Sales Market Share by Type (2016-2021)
Table 12. Global Antibiotic API Revenue by Type (2016-2021) & ($ million)
Table 13. Global Antibiotic API Revenue Market Share by Type (2016-2021)
Table 14. Global Antibiotic API Sale Price by Type (2016-2021)
Table 15. Global Antibiotic API Sales by Application (2016-2021) & (Tons)
Table 16. Global Antibiotic API Sales Market Share by Application (2016-2021)
Table 17. Global Antibiotic API Value by Application (2016-2021)
Table 18. Global Antibiotic API Revenue Market Share by Application (2016-2021)
Table 19. Global Antibiotic API Sale Price by Application (2016-2021)
Table 20. Global Antibiotic API Sales by Company (2019-2021) & (Tons)
Table 21. Global Antibiotic API Sales Market Share by Company (2019-2021)
Table 22. Global Antibiotic API Revenue by Company (2019-2021) ($ Millions)
Table 23. Global Antibiotic API Revenue Market Share by Company (2019-2021)
Table 24. Global Antibiotic API Sale Price by Company (2019-2021)
Table 25. Key Manufacturers Antibiotic API Producing Area Distribution and Sales Area
Table 26. Players Antibiotic API Products Offered
Table 27. Antibiotic API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antibiotic API Sales by Region (2016-2021) (Tons)
Table 31. Global Antibiotic API Sales Market Share by Region (2016-2021)
Table 32. Global Antibiotic API Revenue by Region (2016-2021) & ($ Millions)
Table 33. Global Antibiotic API Revenue Market Share by Region (2016-2021)
Table 34. Americas Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 35. Americas Antibiotic API Sales Market Share by Country (2016-2021)
Table 36. Americas Antibiotic API Revenue by Country (2016-2021) & ($ Millions)
Table 37. Americas Antibiotic API Revenue Market Share by Country (2016-2021)
Table 38. Americas Antibiotic API Sales by Type (2016-2021) & (Tons)
Table 39. Americas Antibiotic API Sales Market Share by Type (2016-2021)
Table 40. Americas Antibiotic API Sales by Application (2016-2021) & (Tons)
Table 41. Americas Antibiotic API Sales Market Share by Application (2016-2021)
Table 42. APAC Antibiotic API Sales by Region (2016-2021) & (Tons)
Table 43. APAC Antibiotic API Sales Market Share by Region (2016-2021)
Table 44. APAC Antibiotic API Revenue by Region (2016-2021) & ($ Millions)
Table 45. APAC Antibiotic API Revenue Market Share by Region (2016-2021)
Table 46. APAC Antibiotic API Sales by Type (2016-2021) & (Tons)
Table 47. APAC Antibiotic API Sales Market Share by Type (2016-2021)
Table 48. APAC Antibiotic API Sales by Application (2016-2021) & (Tons)
Table 49. APAC Antibiotic API Sales Market Share by Application (2016-2021)
Table 50. Europe Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 51. Europe Antibiotic API Sales Market Share by Country (2016-2021)
Table 52. Europe Antibiotic API Revenue by Country (2016-2021) & ($ Millions)
Table 53. Europe Antibiotic API Revenue Market Share by Country (2016-2021)
Table 54. Europe Antibiotic API Sales by Type (2016-2021) & (Tons)
Table 55. Europe Antibiotic API Sales Market Share by Type (2016-2021)
Table 56. Europe Antibiotic API Sales by Application (2016-2021) & (Tons)
Table 57. Europe Antibiotic API Sales Market Share by Application (2016-2021)
Table 58. Middle East & Africa Antibiotic API Sales by Country (2016-2021) & (Tons)
Table 59. Middle East & Africa Antibiotic API Sales Market Share by Country (2016-2021)
Table 60. Middle East & Africa Antibiotic API Revenue by Country (2016-2021) & ($ Millions)
Table 61. Middle East & Africa Antibiotic API Revenue Market Share by Country (2016-2021)
Table 62. Middle East & Africa Antibiotic API Sales by Type (2016-2021) & (Tons)
Table 63. Middle East & Africa Antibiotic API Sales Market Share by Type (2016-2021)
Table 64. Middle East & Africa Antibiotic API Sales by Application (2016-2021) & (Tons)
Table 65. Middle East & Africa Antibiotic API Sales Market Share by Application (2016-2021)
Table 66. Global Antibiotic API Sales Forecast by Type (2021-2026) & (Tons)
Table 67. Global Antibiotic API Sales Market Share Forecast by Type (2021-2026)
Table 68. Global Antibiotic API Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 69. Global Antibiotic API Revenue Market Share Forecast by Type (2021-2026)
Table 70. Global Antibiotic API Sales Forecast by Application (2021-2026) & (Tons)
Table 71. Global Antibiotic API Sales Market Share Forecast by Application (2021-2026)
Table 72. Global Antibiotic API Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 73. Global Antibiotic API Revenue Market Share Forecast by Application (2021-2026)
Table 74. UNITED LABORATORIES Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 75. UNITED LABORATORIES Antibiotic API Product Offered
Table 76. UNITED LABORATORIES Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 77. UNITED LABORATORIES Main Business
Table 78. UNITED LABORATORIES Latest Developments
Table 79. North China Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 80. North China Pharmaceutical Antibiotic API Product Offered
Table 81. North China Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 82. North China Pharmaceutical Main Business
Table 83. North China Pharmaceutical Latest Developments
Table 84. RUIYING PIONEER PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 85. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Product Offered
Table 86. RUIYING PIONEER PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 87. RUIYING PIONEER PHARMACEUTICAL Main Business
Table 88. RUIYING PIONEER PHARMACEUTICAL Latest Developments
Table 89. Centrient Pharmaceuticals Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 90. Centrient Pharmaceuticals Antibiotic API Product Offered
Table 91. Centrient Pharmaceuticals Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 92. Centrient Pharmaceuticals Main Business
Table 93. Centrient Pharmaceuticals Latest Developments
Table 94. Aurobindo Pharma Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 95. Aurobindo Pharma Antibiotic API Product Offered
Table 96. Aurobindo Pharma Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 97. Aurobindo Pharma Main Business
Table 98. Aurobindo Pharma Latest Developments
Table 99. Shyndec Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 100. Shyndec Pharmaceutical Antibiotic API Product Offered
Table 101. Shyndec Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 102. Shyndec Pharmaceutical Main Business
Table 103. Shyndec Pharmaceutical Latest Developments
Table 104. Nectar Lifesciences Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 105. Nectar Lifesciences Antibiotic API Product Offered
Table 106. Nectar Lifesciences Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 107. Nectar Lifesciences Main Business
Table 108. Nectar Lifesciences Latest Developments
Table 109. Harbin Pharmaceutical Group Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 110. Harbin Pharmaceutical Group Antibiotic API Product Offered
Table 111. Harbin Pharmaceutical Group Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 112. Harbin Pharmaceutical Group Main Business
Table 113. Harbin Pharmaceutical Group Latest Developments
Table 114. ACS Dobfar Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 115. ACS Dobfar Antibiotic API Product Offered
Table 116. ACS Dobfar Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 117. ACS Dobfar Main Business
Table 118. ACS Dobfar Latest Developments
Table 119. Novartis Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 120. Novartis Antibiotic API Product Offered
Table 121. Novartis Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 122. Novartis Main Business
Table 123. Novartis Latest Developments
Table 124. CSPC Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 125. CSPC Antibiotic API Product Offered
Table 126. CSPC Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 127. CSPC Main Business
Table 128. CSPC Latest Developments
Table 129. QILU ANTIBIOTICS PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 130. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Product Offered
Table 131. QILU ANTIBIOTICS PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 132. QILU ANTIBIOTICS PHARMACEUTICAL Main Business
Table 133. QILU ANTIBIOTICS PHARMACEUTICAL Latest Developments
Table 134. REYOUNG Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 135. REYOUNG Antibiotic API Product Offered
Table 136. REYOUNG Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 137. REYOUNG Main Business
Table 138. REYOUNG Latest Developments
Table 139. Orchid Pharma Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 140. Orchid Pharma Antibiotic API Product Offered
Table 141. Orchid Pharma Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 142. Orchid Pharma Main Business
Table 143. Orchid Pharma Latest Developments
Table 144. FUAN PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 145. FUAN PHARMACEUTICAL Antibiotic API Product Offered
Table 146. FUAN PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 147. FUAN PHARMACEUTICAL Main Business
Table 148. FUAN PHARMACEUTICAL Latest Developments
Table 149. Dongying Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 150. Dongying Pharmaceutical Antibiotic API Product Offered
Table 151. Dongying Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 152. Dongying Pharmaceutical Main Business
Table 153. Dongying Pharmaceutical Latest Developments
Table 154. FUKANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 155. FUKANG PHARMACEUTICAL Antibiotic API Product Offered
Table 156. FUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 157. FUKANG PHARMACEUTICAL Main Business
Table 158. FUKANG PHARMACEUTICAL Latest Developments
Table 159. Medya Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 160. Medya Pharmaceutical Antibiotic API Product Offered
Table 161. Medya Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 162. Medya Pharmaceutical Main Business
Table 163. Medya Pharmaceutical Latest Developments
Table 164. LUKANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 165. LUKANG PHARMACEUTICAL Antibiotic API Product Offered
Table 166. LUKANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 167. LUKANG PHARMACEUTICAL Main Business
Table 168. LUKANG PHARMACEUTICAL Latest Developments
Table 169. Dawnrays Pharmaceutical Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 170. Dawnrays Pharmaceutical Antibiotic API Product Offered
Table 171. Dawnrays Pharmaceutical Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 172. Dawnrays Pharmaceutical Main Business
Table 173. Dawnrays Pharmaceutical Latest Developments
Table 174. SALUBRIS Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 175. SALUBRIS Antibiotic API Product Offered
Table 176. SALUBRIS Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 177. SALUBRIS Main Business
Table 178. SALUBRIS Latest Developments
Table 179. KELUN Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 180. KELUN Antibiotic API Product Offered
Table 181. KELUN Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 182. KELUN Main Business
Table 183. KELUN Latest Developments
Table 184. HUAFANG PHARMACEUTICAL Basic Information, Antibiotic API Manufacturing Base, Sales Area and Its Competitors
Table 185. HUAFANG PHARMACEUTICAL Antibiotic API Product Offered
Table 186. HUAFANG PHARMACEUTICAL Antibiotic API Sales (Tons), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 187. HUAFANG PHARMACEUTICAL Main Business
Table 188. HUAFANG PHARMACEUTICAL Latest Developments
List of Figures
Figure 1. Picture of Antibiotic API
Figure 2. Antibiotic API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibiotic API Sales Growth Rate 2016-2026 (Tons)
Figure 7. Global Antibiotic API Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Antibiotic API Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Penicillins
Figure 10. Product Picture of Cephalosporins
Figure 11. Product Picture of Aminoglycosides
Figure 12. Product Picture of Tetracyclines
Figure 13. Product Picture of Quinolones
Figure 14. Product Picture of Macrolides
Figure 15. Product Picture of Lincomycins
Figure 16. Product Picture of Others
Figure 17. Global Antibiotic API Sales Market Share by Type in 2020
Figure 18. Global Antibiotic API Revenue Market Share by Type (2016-2021)
Figure 19. Antibiotic API Consumed in Oral Medicine
Figure 20. Global Antibiotic API Market: Oral Medicine (2016-2021) & (Tons)
Figure 21. Antibiotic API Consumed in Injection Medicine
Figure 22. Global Antibiotic API Market: Injection Medicine (2016-2021) & (Tons)
Figure 23. Global Antibiotic API Sales Market Share by Application (2016-2021)
Figure 24. Global Antibiotic API Revenue Market Share by Application in 2020
Figure 25. Global Antibiotic API Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Antibiotic API Revenue Market Share by Company in 2020
Figure 27. Global Antibiotic API Sales Market Share by Regions (2016-2021)
Figure 28. Global Antibiotic API Revenue Market Share by Region in 2020
Figure 29. Americas Antibiotic API Sales 2016-2021 (Tons)
Figure 30. Americas Antibiotic API Revenue 2016-2021 ($ Millions)
Figure 31. APAC Antibiotic API Sales 2016-2021 (Tons)
Figure 32. APAC Antibiotic API Revenue 2016-2021 ($ Millions)
Figure 33. Europe Antibiotic API Sales 2016-2021 (Tons)
Figure 34. Europe Antibiotic API Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Antibiotic API Sales 2016-2021 (Tons)
Figure 36. Middle East & Africa Antibiotic API Revenue 2016-2021 ($ Millions)
Figure 37. Americas Antibiotic API Sales Market Share by Country in 2020
Figure 38. Americas Antibiotic API Revenue Market Share by Country in 2020
Figure 39. Americas Antibiotic API Sales Market Share by Type in 2020
Figure 40. Americas Antibiotic API Sales Market Share by Application in 2020
Figure 41. United States Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Antibiotic API Sales Market Share by Region in 2020
Figure 46. APAC Antibiotic API Revenue Market Share by Regions in 2020
Figure 47. APAC Antibiotic API Sales Market Share by Type in 2020
Figure 48. APAC Antibiotic API Sales Market Share by Application in 2020
Figure 49. China Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Antibiotic API Sales Market Share by Country in 2020
Figure 56. Europe Antibiotic API Revenue Market Share by Country in 2020
Figure 57. Europe Antibiotic API Sales Market Share by Type in 2020
Figure 58. Europe Antibiotic API Sales Market Share by Application in 2020
Figure 59. Germany Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Antibiotic API Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Antibiotic API Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Antibiotic API Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Antibiotic API Sales Market Share by Application in 2020
Figure 68. Egypt Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Antibiotic API Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles


★調査レポート[世界の抗生物質API市場予測 2021年-2026年] (コード：LPI21MY9413)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗生物質API市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗生物質混入骨セメント市場予測 2021年-2026年
    LPI21MY8718 / LP Information / 2021年5月 / LPインフォメーション社の「抗生物質混入骨セメントの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バイタレン、セムフィックス、ジェンタフィックス、その他など、用途別には、整形手術、その他などにセグメント区分してまとめました。抗生物質混入骨セメントのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗生物質混入骨セメントの世界市場概要（サマリー） ・抗生物質混入骨セメントの企業別販売量・売上 ・抗生物質混入骨セメントの企業別市場シェア ・抗生物質混入骨セメントの世界市場規模 2016年-2021年：種類別（バイタレン、セムフィックス、ジェンタフィックス、その他） ・抗生物質混入骨セメントの世界市場規模 2016年-2021年：用途別（整形手術、その他） ・抗生物質混入骨セメントの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗生物質混入骨セメントのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antibiotic Bone Cement will have significant change from previous year. By the most conservative estimates of global Antibiotic Bone Cement market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antibiotic Bone Cement market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antibiotic Bone Cement market by product type,...
  • 世界の製薬アイソレーター市場予測 2021年-2026年
    LPI21MY9192 / LP Information / 2021年5月 / LPインフォメーション社の「製薬アイソレーターの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、無菌試験アイソレーター、無菌生産アイソレーターなど、用途別には、病院＆診断ラボ、製薬＆バイオテクノロジー産業、研究＆学術などにセグメント区分してまとめました。製薬アイソレーターのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・製薬アイソレーターの世界市場概要（サマリー） ・製薬アイソレーターの企業別販売量・売上 ・製薬アイソレーターの企業別市場シェア ・製薬アイソレーターの世界市場規模 2016年-2021年：種類別（無菌試験アイソレーター、無菌生産アイソレーター） ・製薬アイソレーターの世界市場規模 2016年-2021年：用途別（病院＆診断ラボ、製薬＆バイオテクノロジー産業、研究＆学術） ・製薬アイソレーターの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・製薬アイソレーターのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Isolator will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Isolator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 387 million in 2019. Over the next five years the Pharmaceutical Isolator market will register a 2.1% CAGR in terms of revenue, the global market size will reach US$ 420.4 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Isolator market by product type, application, key manufacturers and...
  • 世界の医薬品容器市場予測 2021年-2026年
    LPI21MY9190 / LP Information / 2021年5月 / LPインフォメーション社の「医薬品容器の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ガラス容器、プラスチック容器、金属容器など、用途別には、食品、医療、化学、その他などにセグメント区分してまとめました。医薬品容器のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・医薬品容器の世界市場概要（サマリー） ・医薬品容器の企業別販売量・売上 ・医薬品容器の企業別市場シェア ・医薬品容器の世界市場規模 2016年-2021年：種類別（ガラス容器、プラスチック容器、金属容器） ・医薬品容器の世界市場規模 2016年-2021年：用途別（食品、医療、化学、その他） ・医薬品容器の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・医薬品容器のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Containers will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Containers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Pharmaceutical Containers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Containers market by product type, application, key manufacturers and...
  • 世界の製薬ろ過装置市場予測 2021年-2026年
    LPI21MY9191 / LP Information / 2021年5月 / LPインフォメーション社の「製薬ろ過装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、精密ろ過装置、限外濾過装置、ナノ濾過装置、その他など、用途別には、研究所、契約製造組織、製薬会社などにセグメント区分してまとめました。製薬ろ過装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・製薬ろ過装置の世界市場概要（サマリー） ・製薬ろ過装置の企業別販売量・売上 ・製薬ろ過装置の企業別市場シェア ・製薬ろ過装置の世界市場規模 2016年-2021年：種類別（精密ろ過装置、限外濾過装置、ナノ濾過装置、その他） ・製薬ろ過装置の世界市場規模 2016年-2021年：用途別（研究所、契約製造組織、製薬会社） ・製薬ろ過装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・製薬ろ過装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Pharmaceutical Filtration Equipment will have significant change from previous year. By the most conservative estimates of global Pharmaceutical Filtration Equipment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Pharmaceutical Filtration Equipment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Filtration Equipment market by product type,...
  • 世界の第三世代セファロスポリン市場予測 2021年-2026年
    LPI21MY9671 / LP Information / 2021年5月 / LPインフォメーション社の「第三世代セファロスポリンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、セフォペラゾン＆スルバクタム、セフォペラゾンタゾバクタムなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。第三世代セファロスポリンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・第三世代セファロスポリンの世界市場概要（サマリー） ・第三世代セファロスポリンの企業別販売量・売上 ・第三世代セファロスポリンの企業別市場シェア ・第三世代セファロスポリンの世界市場規模 2016年-2021年：種類別（セフォペラゾン＆スルバクタム、セフォペラゾンタゾバクタム） ・第三世代セファロスポリンの世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・第三世代セファロスポリンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・第三世代セファロスポリンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Third Generation Cephalosporins will have significant change from previous year. By the most conservative estimates of global Third Generation Cephalosporins market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Third Generation Cephalosporins market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Third Generation Cephalosporins market by product type,...
  • 世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年
    LPI21MY9636 / LP Information / 2021年5月 / LPインフォメーション社の「高性能医薬品有効成分（HPAPI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、合成成分、生物学的成分など、用途別には、腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他などにセグメント区分してまとめました。高性能医薬品有効成分（HPAPI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高性能医薬品有効成分（HPAPI）の世界市場概要（サマリー） ・高性能医薬品有効成分（HPAPI）の企業別販売量・売上 ・高性能医薬品有効成分（HPAPI）の企業別市場シェア ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：種類別（合成成分、生物学的成分） ・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：用途別（腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他） ・高性能医薬品有効成分（HPAPI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・高性能医薬品有効成分（HPAPI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of High Performance Active Pharmaceutical Ingredients (HPAPI) will have significant change from previous year. By the most conservative estimates of global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the High Performance Active Pharmaceutical Ingredients (HPAPI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...
  • 世界の注射用エソメプラゾールナトリウム市場予測 2021年-2026年
    LPI21MY9523 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エソメプラゾールナトリウムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、40mg、20mgなど、用途別には、逆流性食道炎、胃潰瘍、急性胃潰瘍、十二指腸潰瘍出血などにセグメント区分してまとめました。注射用エソメプラゾールナトリウムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エソメプラゾールナトリウムの世界市場概要（サマリー） ・注射用エソメプラゾールナトリウムの企業別販売量・売上 ・注射用エソメプラゾールナトリウムの企業別市場シェア ・注射用エソメプラゾールナトリウムの世界市場規模 2016年-2021年：種類別（40mg、20mg） ・注射用エソメプラゾールナトリウムの世界市場規模 2016年-2021年：用途別（逆流性食道炎、胃潰瘍、急性胃潰瘍、十二指腸潰瘍出血） ・注射用エソメプラゾールナトリウムの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・注射用エソメプラゾールナトリウムのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Eseomeprazole Sodium for Injection will have significant change from previous year. By the most conservative estimates of global Eseomeprazole Sodium for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Eseomeprazole Sodium for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Eseomeprazole Sodium for Injection...
  • 世界のシクロスポリン市場予測 2021年-2026年
    LPI21MY9501 / LP Information / 2021年5月 / LPインフォメーション社の「シクロスポリンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤など、用途別には、病院、クリニックなどにセグメント区分してまとめました。シクロスポリンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・シクロスポリンの世界市場概要（サマリー） ・シクロスポリンの企業別販売量・売上 ・シクロスポリンの企業別市場シェア ・シクロスポリンの世界市場規模 2016年-2021年：種類別（錠剤、経口液剤） ・シクロスポリンの世界市場規模 2016年-2021年：用途別（病院、クリニック） ・シクロスポリンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・シクロスポリンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cyclosporine will have significant change from previous year. By the most conservative estimates of global Cyclosporine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cyclosporine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cyclosporine market by product type, application, key manufacturers and key regions and countries....
  • 世界のビタミンD2市場予測 2021年-2026年
    LPI21MY9687 / LP Information / 2021年5月 / LPインフォメーション社の「ビタミンD2の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、飼料用、医薬品用、食品用など、用途別には、飼料産業、製薬産業、食品産業などにセグメント区分してまとめました。ビタミンD2のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ビタミンD2の世界市場概要（サマリー） ・ビタミンD2の企業別販売量・売上 ・ビタミンD2の企業別市場シェア ・ビタミンD2の世界市場規模 2016年-2021年：種類別（飼料用、医薬品用、食品用） ・ビタミンD2の世界市場規模 2016年-2021年：用途別（飼料産業、製薬産業、食品産業） ・ビタミンD2の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ビタミンD2のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Vitamin D2 will have significant change from previous year. By the most conservative estimates of global Vitamin D2 market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Vitamin D2 market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Vitamin D2 market by product type, application, key manufacturers and...

    • ◆H&Iグローバルリサーチのお客様（例）◆